drugset / Trial / NCT00860275
Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of the study is to determine if the concomitant administration of either ketoconazole or fluconazole with BMS-708163 will affect the PK of BMS-708163 and to assess safety and tolerability of BMS-708163
Timeline
- Start
- 2009-04
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Avagacestat | Small molecule | 50 mg | Oral |
| Comparator | Fluconazole | Small molecule | 200 mg | Oral |
| Comparator | Ketoconazole | Small molecule | 400 mg | Oral |